Fate Therapeutics Inc (FATE)

P/OCF Ratio

-2.44×

TTM · Retrieved:

FATE logo

FATE P/OCF Ratio

Current (TTM)-2.44×
FATE Quarterly P/OCF Ratio (-21.21× → -13.87×)
High-resolution chart · PNG

FATE p/ocf ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Fate Therapeutics Inc P/OCF Ratio — Quarterly
Period endingP/OCF Ratio
-13.8719×
-4.6732×
-5.0066×
-6.1516×
-5.3993×
-2.7664×
-6.9916×
-14.0111×
-11.8537×
-21.4638×
-10.0667×
-5.4598×
-16.4386×
-19.3663×
-13.012×
-39.4989×
-45.0786×
-57.8094×
-79.7316×
-169.4353×
-254.9869×
-284.3024×
-384.412×
-113.0018×
70.0533×
-63.1893×
-57.9367×
-52.3952×
-68.2671×
-65.1693×
-75.2055×
-247.6115×
-52.2867×
-41.0302×
-24.897×
-16.6438×
-15.1214×
-25.2605×
-12.371×
-13.3211×
-6.54×
-7.1429×
-13.8706×
-21.4144×
74.4427×
-15.7665×
-16.7572×
-18.9268×
-23.5292×
-37.7123×
-27.0477×
-36.5256×
-37.4091×
-14.9249×
-17.2951×
-21.2064×
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.